Pharmaceutical care and active treatment in patients with osteochondrosis

Abstract

According to the International Classification of Diseases, osteochondrosis is included in the group of diseases of the musculoskeletal system, mainly the spine. The mechanism of the disease is expressed in the disturbance of blood circulation, which nourishes the bone, and hence the damage to bone and cartilage tissue. Objective: This paper aims to present the effect of applied pharmacological and active treatment in 10 patients diagnosed with lumbar osteochondrosis. Methods: We conducted a comprehensive treatment of 10 patients diagnosed with lumbar osteochondrosis without any neurological symptoms during the period 2017–2020. This pharmacological and active treatment lasted from 15 to 17 days. The intensity of the pain symptoms, the general mobility of the spine, and the mobility of the lumbar spine were measured to determine the deficit of the patients. The strength of the flexor and extensor muscles of the body was tested. Results: A decrease in pain intensity, increase in the strength of the abdominal and back muscles and improvement of the mobility of the back muscles were found in all patients after the complex treatment. As a result of the therapy, a reduction in the patient’s dysfunctions and the risk of developing disabilities was found. Conclusion: The application of a multidisciplinary approach in patients with osteochondrosis is of great importance for reducing pain intensity and achieving a good functional recovery of motor and stabilizing function of the muscles of the spine.

A Review of the Treatment for Low Back Pain among Adolescent Athletes

“…Teenagers may experience distinct biopsychosocial characteristics than adults when it comes to the onset of LBP. Adolescence is a time of hormonal change and musculoskeletal system maturity, which is very different from that of adults (Becheva et al, 2023). Besides, Adolescents may respond differently to interventions than adults due to different educational and sociocultural backgrounds, differences in understanding, and differences in adherence to interventions (Leite et al, 2022).…”

The Role of Genomics in the Prevention of Cardiovascular Diseases

“…Traditional cardiovascular disease prevention strategies mainly focus on lifestyle adjustment, control of risk factors (such as hypertension, hyperlipidemia, diabetes, etc. ), and early screening and intervention (Becheva et al, 2023). However, these methods vary significantly among individuals, and some individuals may still develop cardiovascular disease despite following a healthy lifestyle.…”